NCT05249257View on ClinicalTrials.gov

Durability and Safety of CCH With Two Different Injection Techniques in Cellulite With Laxity

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

January 25, 2022

Primary Completion Date

September 12, 2022

Study Completion Date

September 12, 2022

Conditions
CelluliteLaxity; SkinEdematous Fibrosclerotic Panniculopathy
Trial Locations (3)

10021

Endo Clinical Trial Site #1, New York

33146

Endo Clinical Trial Site #2, Coral Gables

70006

Endo Clinical Trial Site #3, Metairie

Sponsors
All Listed Sponsors
lead

Endo Pharmaceuticals

INDUSTRY